These findings demonstrate that the TBX2 subfamily is collectively important for the anti-growth effects of the DNA methyltransferase inhibitor and cancer treatment agent 5-azacytidine in NSCLC cells. This evidence concerns the gene TBX2 and non-small cell lung carcinoma.